RxDoctor Payments Data

Yu Chiu, MD

Physical Medicine & Rehabilitation · Newark, DENPI 1306227640

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (37.6%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Medtronic at 31.1% of the total. Reporting peaked in 2021 at $9,295 and has fallen 86.5% since, to $1,251 in 2025. Among physical medicine & rehabilitation clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,115in general payments, 2019–2025

Across 209 payments — averaging $110.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$7K
  • GRT US Holding, Inc.$6K
  • Abbott$3K
  • Boston Scientific$2K
  • Nevro Corp.$2K
  • Arthrex$1K
  • plus $1K from 15 others
$1,025in research payments, 2019–2025

Across 1 payment — averaging $1025.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$1K

What the payments were for

  • Consulting fees$5,40023%
  • Travel & lodging$8,69938%
  • Food & beverage$7,81634%
  • Education$1,2005%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,115 in reported general payments places this provider in the 95th percentile of 32 physical medicine & rehabilitation providers in Delaware.

See all physical medicine & rehabilitation providers in Delaware

Medicare billing

Part B allowed, 2024
$23,718
Medicare patients
116
Services billed
366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin52$1,071
Pregabalin19$747
Tizanidine Hcl30$563

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →